Fan Meiyan, Yang Wei, Peng Zhiyun, He Yan, Wang Guangcheng
Clinical Trails Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China; Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China.
Clinical Trails Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Bioorg Chem. 2023 Feb;131:106276. doi: 10.1016/j.bioorg.2022.106276. Epub 2022 Nov 17.
In order to find new α-glucosidase inhibitors with high efficiency and low toxicity, novel chromone-based benzohydrazide derivatives 6a-6s were synthesized and characterized through H NMR, C NMR, and HRMS. All the new synthesized compounds were tested for inhibitory activities against α-glucosidase. Compounds 6a-6s with IC values ranging from 4.51 ± 0.09 to 27.21 ± 0.83 μM, showed a potential α-glucosidase inhibitory activity as compared to the positive control (acarbose: IC = 790.40 ± 0.91 μM). Compound 6i exhibited the highest α-glucosidase inhibitory activity with an IC value of 4.51 ± 0.09 μM. Theinteractionbetween α-glucosidase and 6i was further confirmed by enzyme kinetic, fluorescence quenching, circular dichroism, and molecular docking study. In vivo experiment showed that 6i could suppress the rise of blood glucose levels after sucrose loading. The cytotoxicity result indicated that 6i exhibited low cytotoxicity in vitro.
为了寻找高效低毒的新型α-葡萄糖苷酶抑制剂,合成了新型色酮基苯甲酰肼衍生物6a - 6s,并通过氢核磁共振(¹H NMR)、碳核磁共振(¹³C NMR)和高分辨质谱(HRMS)对其进行了表征。对所有新合成的化合物进行了α-葡萄糖苷酶抑制活性测试。6a - 6s化合物的半数抑制浓度(IC)值在4.51 ± 0.09至27.21 ± 0.83 μM之间,与阳性对照(阿卡波糖:IC = 790.40 ± 0.91 μM)相比,显示出潜在的α-葡萄糖苷酶抑制活性。化合物6i表现出最高的α-葡萄糖苷酶抑制活性,IC值为4.51 ± 0.09 μM。通过酶动力学、荧光猝灭、圆二色性和分子对接研究进一步证实了α-葡萄糖苷酶与6i之间的相互作用。体内实验表明,6i可以抑制蔗糖负荷后血糖水平的升高。细胞毒性结果表明,6i在体外表现出低细胞毒性。